## Abstract Tritium‐labeled budesonide was prepared by the selective reduction of a double bond in the butenylenedioxy side chain using carrier‐free tritium and palladium on carbon as a catalyst in absolute ethanol. Although the reduction gave a mixture of the desired product and the expected bypro
Synthesis of deuterium and tritium labelled phenyl glycine
✍ Scribed by M. Kańska
- Book ID
- 112707088
- Publisher
- Springer
- Year
- 1984
- Tongue
- English
- Weight
- 110 KB
- Volume
- 85
- Category
- Article
- ISSN
- 1588-2780
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Levamisole (LEV) i s a w i d e l y used a n t i -p a r a s i t i c agent. I n o r d e r t o c h a r a c t e r i s e t h e biochemical pharmacology o f LEV i n p a r a s i t i c nematodes, [3H]LEV and a more a c t i v e analogue [3H]m-aminolevamisole (MAL) have been prepared. Label1 i n g was accompl
## Abstract A new hepatoprotective agent, N‐(2‐hydroxyethyl)‐maleopimarimidyl morpholide (RU18492) has been synthesised labelled with tritium at C‐3, C‐4a, C‐10 and in the C‐isopropyl group. The incorporation of tritium relies on the acid‐catalysed isomerisation of levopimaric acid (4) to abietic a
## Abstract The preparations of nicotin[2′,4′,6,‐^2^H~3~]anilide, 4′‐Cl‐nicotin[2′,6′‐^2^H~2~]anilide, 4′‐X‐nicotin[ar‐^3^H]anilide, (X = H−, CH~3~‐, Cl‐ or No~2~‐) and[6‐^14^C]nicotin[ar‐^3^H]anilide are described.